Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206 - Ribas, A; Camacho, L H; Lopez-Berestein, G (J Clin Oncol, 2005)
et al.